I don't disagree with a lot you say other than the fact about the marketing of these results to there lead up then meh nothing too fantastic. Not the best strategy on PM
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ASX Market Open: Powell hope to power Santa rally through French gov't collapse, South Korean crisis | Dec 5, 2024